• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Pacira Pharmaceuticals, Inc. (PCRX)

    -NasdaqGS
    69.54 Down 0.46(0.66%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 58,316   61,792   52,048   47,166  
    Cost of Revenue17,580  18,968  20,391  19,954  
    Gross Profit 40,736   42,824   31,657   27,212  
    Operating Expenses
    Research Development5,967  3,887  4,424  5,216  
    Selling General and Administrative31,428  31,019  28,217  24,837  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 3,341   7,918   (984) (2,841)
    Income from Continuing Operations
    Total Other Income/Expenses Net(33)113  17  (118)
    Earnings Before Interest And Taxes3,308  8,031  (967)(2,959)
    Interest Expense1,996  2,056  2,037  2,078  
    Income Before Tax1,312  5,975  (3,004)(5,037)
    Income Tax Expense52  173   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops1,260  5,802  (3,004)(5,037)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 1,260   5,802   (3,004) (5,037)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 1,260   5,802   (3,004) (5,037)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.